fashion -WSS

fashion

author：fashion 2025-09-30 22:04:34 - browse：416

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： In diabetes hearing, Sanders takes on a new foe: food makers

focus

WSS

Ukrainian soldiers say they owe lives to US

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Teach medical students about patients with intellectual disabilities

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

The simple reason for the increase in autism diagnosis

After sickle

hotspot

fashion

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA approves world's first CRISPR

Apple is now the first public company to be valued at $3 trillion

Illumina to lay off 10% of research and development team

Jerome Adams on the need for new antivirals for Covid

In diabetes hearing, Sanders takes on a new foe: food makers

Hepatitis C has a cure — but many Americans still lack access to it

Supreme Court strikes down Biden student loan forgiveness program

Drug repurposing or repositioning? The language matters

Synthetic human embryos? Researchers say term is overblown

focus

FDA approves world's first CRISPR

What PEPFAR has meant on the ground in Ukraine

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

What causes an itch? Researchers may have solved the mystery

Americans' trust in science, scientist continues decline: Report

Thousands protest in Iraq for a second day over burning of Quran in Sweden

entertainment

focus

focus

explore